Renal vasodepressor mechanisms: the medullipin system

  title={Renal vasodepressor mechanisms: the medullipin system},
  author={E. Eric Muirhead},
  journal={Journal of Hypertension},
  • E. Muirhead
  • Published 1 December 1993
  • Medicine, Biology
  • Journal of Hypertension
Renal vasodepressor hormone Medullipin I is the renomedullary vasodepressor hormone secreted by the renomedullary interstitial cells of the renal papilla. It is conveyed to the liver where it is converted to its active form, medullipin II. Medullipin II is a vasodilator that suppresses sympathetic tone and causes diuresis and natriuresis. Its actions are opposite to those of angiotensin II. These are feedback control systems. The secretion and conversion of medullipin is related to the… 

Production and Actions of the Anandamide Metabolite Prostamide E2 in the Renal Medulla

The results suggest that AEA and/or its prostamide metabolites in the renal medulla may represent medullipin and function as a regulator of body fluid and MAP.

Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension.

Evidence is provided to suggest that the combined effect of enhanced tubuloglomerular feedback and impaired pressure natriuresis results in a defect in NaCl excretion which results in the development of persistent hypertension.

Physiological regulation of prostaglandins in the kidney.

COXs, prost anoid synthases, and prostanoid receptors should provide fruitful targets for intervention in the pharmacological treatment of renal disease.

Physiologic and pathophysiologic roles of lipid mediators in the kidney.

Ceramide has also been demonstrated to be an important signaling molecule, which is involved in pathogenesis of acute kidney injury caused by ischemia/reperfusion, and toxic insults, which should provide fruitful targets for intervention in the pharmacologic treatment of renal disease.

Renal papillary tip extract stimulates BNP production and excretion from cardiomyocytes

Results suggested that the papillary tip express a substance that can stimulate BNP production and secretion from cardiomyocytes, and were suggested to support the existence of BNP isoforms or other nucleotide expression apart from BNP and tdTomato.

BNP as a Major Player in the Heart-Kidney Connection

The functions and the roles of BNP in the heart-kidney interaction are reviewed and the relevant molecular mechanisms that suggest BNP is protective against chronic kidney diseases and heart failure are discussed.

Anandamide and its metabolites: what are their roles in the kidney?

The current knowledge of the roles of AEA and its derivatives highlights the need for further research to define and potentially exploit the role of this endocannabinoid system in the kidney.

Purification of class I medullipins from the venous effluent of isolated normal kidneys perfused under high pressure with saline.

The results show that Med I, as defined by previous physiologic and pharmacologic criteria, is not a single molecule.

Renal medullary blood flow and renal medullary antihypertensive mechanisms.

A unified hypothesis for blood pressure control is outlined via a combination of the plasma volume regulating pressure-natriuresis mechanism and the powerful antihypertensive actions of the "medullipins" (i.e. vasodilatation, inhibition of sympathetic drive and a diuretic action).